Control group:dexamethasone

4 trials

Sponsors

Department of Hematology, Xiniao Hospital, The First Affiliated Hospital of Dalian Medical University, Jinshan Hospital, Fudan University

Conditions

Adult newly diagnosed ITPprimary immune thrombocytopenia

Phase 4

Dexamethasone and dexamethasone combined with sirolimus in the treatment of adult newly diagnosed ITP: a multicenter, randomized, controlled, open trial

Active, not recruitingChiCTR1900020657

Department of Hematology, Xiniao HospitalAdult newly diagnosed ITP

Start: 2019-03-07Updated: 2019-01-14

Huaiqi huang Granules combined with dexamethasone in the treatment of adult primary immune thrombocytopenia: a single center, randomized, controlled and open trial

RecruitingChiCTR2100042610

The First Affiliated Hospital of Dalian Medical UniversityAdult newly diagnosed ITP

Start: 2021-01-24Updated: 2021-05-03

Huaiqi huang Granules combined with dexamethasone in the treatment of adult primary immune thrombocytopenia: a single center, randomized, controlled and open trial

RecruitingITMCTR2100004313

The First Affiliated Hospital of Dalian Medical UniversityAdult newly diagnosed ITP

Start: 2021-01-24Updated: 2023-02-20

Efficacy and safety study of corticosteroids plus hydroxychloroquine in first-line treatment of patients with primary immune thrombocytopenia with positive antinuclear antibody

RecruitingChiCTR2100045747

Jinshan Hospital, Fudan Universityprimary immune thrombocytopenia

Start: 2020-12-01Updated: 2021-12-06

Related Papers

Sirolimus Combined Dexamethasone As the First-Line Therapy for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Open-Label, Prospective, Randomized Controlled Clinical Trial

Blood2024-11-05

Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study

Frontiers in Medicine2020-03-3137 citations